Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	68.00	59.62	35.49
Graham Fair Price	58.03	0.67	0.42
PEG	-80.85	0.12	0.61
Price/Book	10.91	5.59	5.04
Price/Cash Flow	-56.85	-9.94	23.04
Prices/Earnings	-56.87	17.89	41.49
Price/Sales	-38.96	4.06	6.65
Price/FCF	-56.85	-9.94	23.04
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-54.00	0.18	0.38
Operating Margin	-46.46	0.09	0.16
ROA	187.74	< 0.005	< 0.005
ROE	0.03	0.08	157.16
ROIC	< 0.005	< 0.005	67.34
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	39.29
Dividends QOQ	-0.31	-0.22	29.62
EBIT QOQ	3.86	-0.04	-98.93
EPS QOQ	0.68	1.54	125.17
FCF QOQ	4.36	-3.53	-18.94
Revenue QOQ	-0.43	0.79	83.88
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	107.85	54.68	-49.30
Days Sales Outstanding (DSO)	594.35	301.35	-49.30
Inventory Turnover	0.83	1.65	97.24
Debt/Capitalization	0.89	0.89	0.26
Quick Ratio	0.72	0.88	22.68
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	0.51	0.50	-1.45
Cash	0.21	0.18	-15.06
Capex	< 0.005	< 0.005	65.63
Free Cash Flow	0.11	-0.28	153.33
Revenue	0.39	0.69	79.06
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.79	1.00	26.60
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	21.33	34.80	63.17
Naive Interpretation	Member

06 - Financial Health · Bad

Rating